Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Nykode Therapeutics ASA AGM Information 2021

Dec 22, 2021

3695_rns_2021-12-22_a37e39f3-4077-4eb3-8e37-f8a482aff726.pdf

AGM Information

Open in viewer

Opens in your device viewer

Denne protokollen er utferdiget både på norsk og på engelsk. Ved uoverensstemmelser mellom de to versjonene, skal den norske versjonen gå foran.

PROTOKOLL FRA EKSTRAORDINÆR GENERALFORSAMLING I NYKODE THERAPEUTICS AS

Ekstraordinær generalforsamling i Nykode Therapeutics AS ("Selskapet") ble avholdt på møterom VIA - Bygg G, Plan 0 i Gaustadalléen 21, Oslo, den 22. desember 2021 kl. 10:00.

En liste over fremmøtte aksjonærer og fullmakter er inntatt som Vedlegg 1 til denne protokollen. Av vedlegget fremgår også antall aksjer og prosentandel av Selskapets aksjekapital som var representert på generalforsamlingen.

1. VALG AV MØTELEDER OG ÉN PERSON TIL Å MEDSIGNERE PROTOKOLLEN

Anders Tuv ble valgt som møteleder, og Harald Gurvin ble valgt til å medundertegne protokollen sammen med møteleder.

2. GODKJENNELSE AV INNKALLING OG DAGSORDEN

3. VALG AV NY STYRELEDER OG ENDRINGER I STYRET

I samsvar med valgkomitéens forslag, fattet generalforsamlingen følgende vedtak:

These minutes has been prepared both in Norwegian and in English. In case of discrepancies between the two versions, the Norwegian version shall prevail.

MINUTES OF THE EXTRAORDINAY GENERAL MEETING IN NYKODE THERAPEUTICS AS

The Extraordinary General Meeting of Nykode Therapeutics AS (the "Company") was held at meeting room VIA - Building G, Floor 0 in Gaustadalléen 21, Oslo, Norway at 10:00 CET on December 22, 2021.

Styrets leder, Anders Tuv, åpnet generalforsamlingen. The Chair of the Board, Anders Tuv, opened the General Meeting.

A list of shareholders in attendance and proxies is included as Appendix 1 to these minutes. The appendix also states the number of shares and the percentage of the Company's share capital that were represented at the General Meeting.

Følgende saker forelå på agendaen: The following items were on the agenda:

1. ELECTION OF CHAIR OF THE MEETING AND ONE PERSON TO CO-SIGN THE MINUTES

Anders Tuv was appointed as chair of the meeting, and Harald Gurvin was appointed to co-sign the minutes with the chair.

2. APPROVAL OF NOTICE AND AGENDA

Innkalling og dagsorden for møtet ble godkjent. The notice and the agenda for the meeting were approved.

3. ELECTION OF NEW CHAIR OF THE BOARD AND CHANGES TO THE BOARD

In accordance with the proposal by the Nomination Committee, the General Meeting passed the following resolution:

Martin Nicklasson velges som ny styreleder, Anders Tuv velges som medlem av styret og Trygve Lauvdal trer ut av styret og fortsetter som observatør til styret.

4. HONORAR TIL STYRELEDER OG STYREMEDLEM

I samsvar med valgkomitéens forslag, fattet generalforsamlingen følgende vedtak:

Martin Nicklasson vil motta et honorar på USD 80,000, beregnet pro-rata fra datoen for den ekstraordinære generalforsamlingen til datoen for den ordinære generalforsamlingen i 2022.

Martin Nicklasson blir tildelt 300 000 opsjoner med en utøvelseskurs på NOK 100 per aksje. Opsjonene vil opptjenes med 100 000 den 1. januar 2023, 100 000 den 1. januar 2024 og 100 000 den 1. januar 2025. Opsjonen vil utløpe den 31. mars 2025. Andre vilkår i henhold til selskapets opsjonsprogram.

Anders Tuv vil motta fullt honorar på NOK 400 000 i henhold til vedtaket på den ordinære generalforsamlingen 5. mai 2021.

Anders Tuv vil motta honorar på NOK 200 000, beregnet pro-rata fra datoen for den ekstraordinære generalforsamlingen til datoen for den ordinære generalforsamlingen i 2022.

Martin Nicklasson is elected as new Chair of the Board, Anders Tuv is elected as Board member and Trygve Lauvdal steps down from the Board and continues as observer to the Board.

4. REMUNERATION TO THE CHAIR OF THE BOARD AND BOARD MEMBER

In accordance with the proposal by the Nomination Committee, the General Meeting passed the following resolution:

Martin Nicklasson will receive a remuneration of USD 80,000, calculated on a pro-rata basis from the date of the Extraordinary General Meeting until the date of the Annual General Meeting in 2022

Martin Nicklasson is granted 300,000 share options with a strike price of NOK 100 per share. The share options will vest with 100,000 on 1 January 2023, 100,000 on 1 January 2024 and 100,000 on 1 January 2025. The share options will expire on 31 March 2025. Other terms and conditions as per the company's share option scheme.

Anders Tuv will receive the full remuneration of NOK 400,000 in accordance with the resolution passed by the Annual General Meeting on 5 May 2021.

Anders Tuv will receive a remuneration of NOK 200,000, calculated on a pro-rate basis from the date of the Extraordinary General Meeting until the date of the Annual General Meeting in 2022.

– – – – – –

Voteringsresultatet for det enkelte vedtak fremgår av Vedlegg 2 til generalforsamlingsprotokollen.

Det forelå ikke ytterligere saker til behandling. Møteleder erklærte generalforsamlingen for hevet.

The voting result for each matter is presented in Appendix 2 to the minutes of the General Meeting.

There were no other matters on the agenda. The chair of the meeting declared the General Meeting adjourned.

* * *

Oslo 22. desember 2021 / December 22, 2021

________________________ ________________________

Chair of the meeting Co-signatory

Anders Tuv (sign.) Harald Gurvin (sign.) Møteleder Medundertegner

Total Represented

ISIN: NO0010714785 VACCIBODY AS A-AKSJER
General meeting date: 22/12/2021 10.00
Today: 22.12.2021

Number of persons with voting rights represented/attended : 1

Number of shares % sc
Total shares 289,619,409
- own shares of the company 0
Total shares with voting rights 289,619,409
Represented by advance vote 67,001,925 23.13 %
Sum own shares 67,001,925 23.13 %
Represented by proxy 8,025 0.00 %
Represented by voting instruction 71,998,991 24.86 %
Sum proxy shares 72,007,016 24.86 %
Total represented with voting rights 139,008,941 48.00 %
Total represented by share capital 139,008,941 48.00 %

Registrar for the company:

NORDEA BANK ABP, FILIAL NORGE

_______________________________

VACCIBODY AS A-AKSJER

_______________________________

Signature company:

Protocol for general meeting VACCIBODY AS A-AKSJER

ISIN: NO0010714785 VACCIBODY AS A-AKSJER General meeting date: 22/12/2021 10.00 Today: 22.12.2021

Shares class FOR Against Abstain Poll in Poll not registered Represented shares
with voting rights
Agenda item 1 Election of chair of the meeting and one person to co-sign the minutes
A - aksje 139,010,041 0 0 139,010,041 0 139,010,041
votes cast in % 100.00 % 0.00 % 0.00 %
representation of sc in % 100.00 % 0.00 % 0.00 % 100.00 % 0.00 %
total sc in % 48.00 % 0.00 % 0.00 % 48.00 % 0.00 %
Total 139,010,041 0 0 139,010,041 0 139,010,041
Agenda item 2 Approval of notice and agenda
A - aksje 139,010,041 0 0 139,010,041 0 139,010,041
votes cast in % 100.00 % 0.00 % 0.00 %
representation of sc in % 100.00 % 0.00 % 0.00 % 100.00 % 0.00 %
total sc in % 48.00 % 0.00 % 0.00 % 48.00 % 0.00 %
Total 139,010,041 0 0 139,010,041 0 139,010,041
Agenda item 3 Election of new chair of board and changes to the board
A - aksje 137,304,943 1,705,098 0 139,010,041 0 139,010,041
votes cast in % 98.77 % 1.23 % 0.00 %
representation of sc in % 98.77 % 1.23 % 0.00 % 100.00 % 0.00 %
total sc in % 47.41 % 0.59 % 0.00 % 48.00 % 0.00 %
Total 137,304,943 1,705,098 0 139,010,041 0 139,010,041
Agenda item 4 Remuneration to the chair of board and board member
A - aksje 137,304,943 1,705,098 0 139,010,041 0 139,010,041
votes cast in % 98.77 % 1.23 % 0.00 %
representation of sc in % 98.77 % 1.23 % 0.00 % 100.00 % 0.00 %
total sc in % 47.41 % 0.59 % 0.00 % 48.00 % 0.00 %
Total 137,304,943 1,705,098 0 139,010,041 0 139,010,041

Registrar for the company:

Signature company:

NORDEA BANK ABP, FILIAL NORGE

_______________________________

_______________________________

VACCIBODY AS A-AKSJER

Share information

Name Total number of shares Nominal value Share capital Voting rights
A - aksje 289,619,409 0.01 2,896,194.09 Yes
Sum:

§ 5-17 Generally majority requirement

requires majority of the given votes

§ 5-18 Amendment to resolution

Requires two-thirds majority of the given votes like the issued share capital represented/attended on the general meeting